AMY WALL: Open Payments
NPI 1346751195 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 45 payments from 12 companies in 2025. Trend: 2023 $1,344 · 2024 $1,221 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $219 |
| PFIZER INC. | 11 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $160 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| Inspire Medical Systems, Inc. | 1 | $84 |
| Alnylam Pharmaceuticals Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Philips North America LLC | 2 | $36 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
Products named: JARDIANCE, LOKELMA, VYNDAQEL, VERQUVO, ELIQUIS, INSPIRE, AMVUTTRA, WAINUA.
Industry payments across MS — which companies pay providers there.
